Kaleido Biosciences Stock Working Capital
Kaleido Biosciences fundamentals help investors to digest information that contributes to Kaleido Biosciences' financial success or failures. It also enables traders to predict the movement of Kaleido Pink Sheet. The fundamental analysis module provides a way to measure Kaleido Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kaleido Biosciences pink sheet.
Kaleido |
Kaleido Biosciences Company Working Capital Analysis
Kaleido Biosciences' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Kaleido Biosciences Working Capital | 62.54 M |
Most of Kaleido Biosciences' fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kaleido Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionBased on the company's disclosures, Kaleido Biosciences has a Working Capital of 62.54 M. This is 85.31% lower than that of the Pharmaceuticals sector and 88.39% lower than that of the Health Care industry. The working capital for all United States stocks is 95.77% higher than that of the company.
Kaleido Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kaleido Biosciences' direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Kaleido Biosciences could also be used in its relative valuation, which is a method of valuing Kaleido Biosciences by comparing valuation metrics of similar companies.Kaleido Biosciences is currently under evaluation in working capital category among its peers.
Kaleido Fundamentals
Return On Equity | -5.81 | ||||
Return On Asset | -1.0 | ||||
Operating Margin | (79.28) % | ||||
Current Valuation | (16.73 M) | ||||
Shares Outstanding | 42.62 M | ||||
Shares Owned By Insiders | 0.73 % | ||||
Shares Owned By Institutions | 0.36 % | ||||
Number Of Shares Shorted | 2.34 M | ||||
Price To Earning | (1.45) X | ||||
Price To Book | 0 X | ||||
Price To Sales | 0.04 X | ||||
Revenue | 1.1 M | ||||
Gross Profit | (66.7 M) | ||||
EBITDA | (85.09 M) | ||||
Net Income | (90.29 M) | ||||
Cash And Equivalents | 38.47 M | ||||
Cash Per Share | 0.90 X | ||||
Total Debt | 5.55 M | ||||
Debt To Equity | 2.04 % | ||||
Current Ratio | 1.42 X | ||||
Book Value Per Share | 0.25 X | ||||
Cash Flow From Operations | (77.09 M) | ||||
Short Ratio | 29.34 X | ||||
Earnings Per Share | (2.16) X | ||||
Target Price | 22.0 | ||||
Number Of Employees | 76 | ||||
Beta | 0.42 | ||||
Market Capitalization | 421.96 K | ||||
Total Asset | 50.14 M | ||||
Retained Earnings | (197.63 M) | ||||
Working Capital | 62.54 M | ||||
Current Asset | 72.93 M | ||||
Current Liabilities | 10.39 M | ||||
Z Score | -6.3 | ||||
Net Asset | 50.14 M |
Pair Trading with Kaleido Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kaleido Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kaleido Biosciences will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to PPL could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PPL when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PPL - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PPL Corporation to buy it.
The correlation of PPL is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PPL moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PPL Corporation moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PPL can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Kaleido Pink Sheet
If you are still planning to invest in Kaleido Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kaleido Biosciences' history and understand the potential risks before investing.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Transaction History View history of all your transactions and understand their impact on performance | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |